ACVC Premium Access

Do we really need aspirin?

Congress Presentation

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
33 presentations
9 followers

4 more presentations in this session

The novel subcutaneously administered glycoprotein IIb/IIIa antagonist RUC-4 (Zalunfiban) did not cause thrombocytopenia in the phase 2a study of patients with ST-elevation myocardial infarction

Speaker: Mr S. Rikken (Nieuwegein, NL)

Thumbnail

Antiplatelet pretreatment in NSTE-ACS: do we have the answer?

Speaker: Doctor P. Capranzano (Catania, IT)

Thumbnail

Extended, standard or de-escalation antiplatelet therapy after ACS?

Speaker: Professor K. Huber (Vienna, AT)

Thumbnail

Anti-thrombotic management in patients with acute coronary syndromes - discussion.

Thumbnail

Access the full session

Anti-thrombotic management in patients with acute coronary syndromes (ACS)

Speakers: Professor R. Mehran, Mr S. Rikken, Doctor P. Capranzano, Professor K. Huber
Thumbnail

About the event

Image

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

Sessions Presentations

Related content

ESC Premium Access

Who should be treated with an SGLT2 inhibitor?

30 August 2021

ESC 365 is supported by

logo Novo Nordisk